A Phase 1 interventional study of Tramadol hydrochloride/Acetaminophen Tab. and Tramadol hydrochloride/Acetaminophen SR Tab. in Low Back Pain, sponsored by Daewon Pharmaceutical Co., Ltd.. Completed. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2013-01-28.
Sponsored by Daewon Pharmaceutical Co., Ltd. · Phase 1 and Interventional
The purpose of this study is to evaluate effectness of Tramadol Hydrochloride/Acetaminophen SR Tab. and Tramadol Hydrochloride/Acetaminophen Tab. in patients with low back pain.
2,373 studies on the registry are indexed under Back Pain; 284 are open to participants now.
Browse Back Pain studies →Daewon Pharmaceutical Co., Ltd. is the lead sponsor of 48 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Drug: Tramadol hydrochloride/Acetaminophen Tab.
Drug: Tramadol hydrochloride/Acetaminophen SR Tab.
Changes in '100 mm pain VAS' value from baseline
Time frame: 0, 1, 7, 14, 28 day
No study locations are listed for this record.
This study is completed, as verified in Jan 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Daewon Pharmaceutical Co., Ltd.